Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects

被引:0
作者
Chan, Phyllis [1 ]
Mould, Diane R. [2 ]
AbuTarif, Malaz [1 ]
Wen, Jessica [3 ]
Chang, Mei-Hwei [4 ]
Emerick, Karan [5 ]
Reynolds, Laurie [1 ]
Bertz, Richard [1 ]
Bifano, Marc [1 ]
机构
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Project Res Inc, Phoenixville, PA USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Univ Connecticut, Hartford, CT 06112 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
W-64
引用
收藏
页码:S104 / S104
页数:1
相关论文
共 50 条
[31]   Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout [J].
Yue, Corinne Seng ;
Huang, William ;
Alton, Michelle ;
Maroli, Allan N. ;
Waltrip, Royce W. ;
Wright, David ;
Di Marco, Marika .
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (06) :708-718
[32]   Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects [J].
Mario González-Sales ;
Olivier Barrière ;
Pierre Olivier Tremblay ;
Fahima Nekka ;
Jean-Claude Mamputu ;
Sylvie Boudreault ;
Mario Tanguay .
Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 :287-299
[33]   Population pharmacokinetic/pharmacodynamic modelling of eltrombopag in healthy volunteers and subjects with chronic liver disease [J].
Farrell, Colm ;
Hayes, Siobhan C. ;
Wire, Mary ;
Zhang, Jianping .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (03) :532-544
[34]   Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects [J].
Rambiritch, Virendra ;
Naidoo, Poobalan ;
Pillai, Goonaseelan .
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 :141-153
[35]   Population Pharmacokinetic/Pharmacodynamic Evaluation of the Effect of Glasdegib on QT Interval in Healthy Adult Subjects [J].
Masters, Joanna C. ;
Shaik, Naveed .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 :S58-S58
[36]   Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects [J].
Gonzalez-Sales, Mario ;
Barriere, Olivier ;
Tremblay, Pierre Olivier ;
Nekka, Fahima ;
Mamputu, Jean-Claude ;
Boudreault, Sylvie ;
Tanguay, Mario .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 (03) :287-299
[37]   POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF EPTIFIBATIDE IN THE INHIBITION OF PLATELET AGGREGATION IN HEALTHY CHINESE SUBJECTS [J].
Li, Qinmei ;
Zhang, Hong ;
Wu, Min ;
Liu, Jingrui ;
Li, Cuiyun ;
Ding, Yanhua .
DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) :S83-S84
[38]   Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses to Support Olaparib Tablet Approval in Ovarian Cancer [J].
Xu, Hongmei ;
Zhou, Diansong ;
Li, Jianguo ;
Berges, Alienor ;
Bui, Khanh ;
Milenkova, Tsveta ;
Tomkinson, Helen ;
Al-Huniti, Nidal ;
Learoyd, Maria .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 :S36-S36
[39]   PHARMACOKINETIC AND PHARMACODYNAMIC RESPONSE TO NICOTINE IN NAIVE SUBJECTS [J].
BLUMHARDT, CL ;
NEWHOUSE, PA ;
NARANG, PK ;
NGUYEN, HT ;
SUNDERLAND, T ;
MURPHY, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) :165-165
[40]   Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body Sizes [J].
Lakota, Elizabeth A. ;
Landersdorfer, Cornelia B. ;
Zhang, Li ;
Nafziger, Anne N. ;
Bertino, Joseph S., Jr. ;
Bhavnani, Sujata M. ;
Forrest, Alan .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)